A specific class of anti-inflammatory drugs can help children avoid a debilitating complication of Crohn's disease, a new ...

Intestines suffer a lot of wear and tear in their daily service to digestion, requiring constant renewal of their lining.

Vedolizumab prevented the postoperative recurrence of Crohn’s disease and should be considered a prophylactic treatment in ...

June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an ... Major Cause of Inflammatory ...

A study by University of Michigan researchers may provide an explanation for why some patients with Crohn's disease continue ...

Early treatment of pediatric Crohn's disease with anti-tumor necrosis factor medications can substantially reduce the risk of ...

Nutrients specific to the Mediterranean diet could help with symptom management in inflammatory bowel disease, evidence ...

Israel's Teva Pharmaceutical Industries and French drugmaker Sanofi said a study of a drug to treat ulcerative colitis and ...

Teva Pharmaceuticals and Sanofi announced positive results in a Phase 2b trial of their drug for ulcerative colitis and Crohn ...

Teva Pharmaceutical Industries continues to impress investors with strong sales growth and promising development. Click here ...